GW679769

DRUG13 trials

Sponsors

GlaxoSmithKline

Conditions

Chemotherapy-InducedChemotherapy-Induced Nausea and VomitingDepressionDepressive DisorderDepressive Disorder, MajorFibromyalgiaIncontinence, Urinary and Urinary Bladder, OveractiveInsomnia

Phase 1

fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder

CompletedNCT00332046

GlaxoSmithKlineSocial Anxiety Disorder

Start: 2006-01-31Target: 57Updated: 2008-10-16

Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment

CompletedNCT00359177

GlaxoSmithKlineVomiting

Start: 2005-12-01End: 2006-10-12Updated: 2017-09-25

Phase 2

Study Of GW679769 In Major Depressive Disorder

CompletedNCT00102492

GlaxoSmithKlineDepressive Disorder, Major, Major Depressive Disorder (MDD)

Start: 2004-10-31End: 2006-09-30Updated: 2015-04-16

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

CompletedNCT00104403

GlaxoSmithKlineChemotherapy-Induced Nausea and Vomiting, Nausea and Vomiting, Chemotherapy-Induced

Start: 2004-12-31End: 2006-01-31Updated: 2015-04-16

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

CompletedNCT00169572

GlaxoSmithKlineChemotherapy-Induced, Nausea and Vomiting

Start: 2005-02-28Target: 492Updated: 2010-05-10

Post-Operative Nausea And Vomiting Study In Female Patients

CompletedNCT00274690

GlaxoSmithKlineNausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting

Start: 2005-02-28End: 2005-08-31Updated: 2017-01-20

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

CompletedNCT00280436

GlaxoSmithKlineInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2006-01-31End: 2007-03-31Updated: 2015-04-16

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

CompletedNCT00280423

GlaxoSmithKlineInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2006-01-31End: 2007-02-28Updated: 2015-04-15

Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients

TerminatedNCT00332319

GlaxoSmithKlineIncontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder

Start: 2006-01-31End: 2007-02-28Updated: 2015-04-17

Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

CompletedNCT00354809

GlaxoSmithKlineInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2006-05-31End: 2007-07-31Updated: 2015-04-16

Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

CompletedNCT00413023

GlaxoSmithKlineDepressive Disorder, Major

Start: 2005-06-30End: 2006-09-30Updated: 2016-10-28

A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia

CompletedNCT00650871

GlaxoSmithKlineSleep Initiation and Maintenance Disorders

Start: 2004-07-30End: 2005-08-30Updated: 2017-08-08

Unknown Phase

GW679769 In Fibromyalgia

CompletedNCT00264628

GlaxoSmithKlineDepression, Depressive Disorder, Fibromyalgia

Start: 2005-10-31End: 2006-09-30Updated: 2015-04-16